1. Home
  2. WVE vs UVSP Comparison

WVE vs UVSP Comparison

Compare WVE & UVSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • UVSP
  • Stock Information
  • Founded
  • WVE 2012
  • UVSP 1876
  • Country
  • WVE Singapore
  • UVSP United States
  • Employees
  • WVE N/A
  • UVSP N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • UVSP Major Banks
  • Sector
  • WVE Health Care
  • UVSP Finance
  • Exchange
  • WVE Nasdaq
  • UVSP Nasdaq
  • Market Cap
  • WVE 915.6M
  • UVSP 881.8M
  • IPO Year
  • WVE 2015
  • UVSP 1989
  • Fundamental
  • Price
  • WVE $8.40
  • UVSP $29.38
  • Analyst Decision
  • WVE Strong Buy
  • UVSP Hold
  • Analyst Count
  • WVE 14
  • UVSP 3
  • Target Price
  • WVE $19.86
  • UVSP $29.00
  • AVG Volume (30 Days)
  • WVE 1.6M
  • UVSP 125.7K
  • Earning Date
  • WVE 07-30-2025
  • UVSP 07-23-2025
  • Dividend Yield
  • WVE N/A
  • UVSP 2.96%
  • EPS Growth
  • WVE N/A
  • UVSP 12.34
  • EPS
  • WVE N/A
  • UVSP 2.73
  • Revenue
  • WVE $104,939,000.00
  • UVSP $298,354,000.00
  • Revenue This Year
  • WVE N/A
  • UVSP $11.24
  • Revenue Next Year
  • WVE $4.90
  • UVSP $4.30
  • P/E Ratio
  • WVE N/A
  • UVSP $10.88
  • Revenue Growth
  • WVE N/A
  • UVSP 4.09
  • 52 Week Low
  • WVE $5.04
  • UVSP $22.83
  • 52 Week High
  • WVE $16.74
  • UVSP $32.86
  • Technical
  • Relative Strength Index (RSI)
  • WVE 63.68
  • UVSP 37.26
  • Support Level
  • WVE $7.69
  • UVSP $30.93
  • Resistance Level
  • WVE $8.70
  • UVSP $32.43
  • Average True Range (ATR)
  • WVE 0.53
  • UVSP 0.81
  • MACD
  • WVE 0.07
  • UVSP -0.31
  • Stochastic Oscillator
  • WVE 82.63
  • UVSP 7.89

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About UVSP Univest Financial Corporation

Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.

Share on Social Networks: